22-25877926-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032608.7(MYO18B):c.4225-33G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 1,537,184 control chromosomes in the GnomAD database, including 164,693 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Genomes: 𝑓 0.44 ( 14898 hom., cov: 32)
Exomes 𝑓: 0.46 ( 149795 hom. )
Consequence
MYO18B
NM_032608.7 intron
NM_032608.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0300
Genes affected
MYO18B (HGNC:18150): (myosin XVIIIB) The protein encoded by this gene may regulate muscle-specific genes when in the nucleus and may influence intracellular trafficking when in the cytoplasm. The encoded protein functions as a homodimer and may interact with F actin. Mutations in this gene are associated with lung cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
This place is a probable branch point but likely benign (scored 0 / 10). Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 22-25877926-G-C is Benign according to our data. Variant chr22-25877926-G-C is described in ClinVar as [Benign]. Clinvar id is 1243210.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.559 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO18B | NM_032608.7 | c.4225-33G>C | intron_variant | ENST00000335473.12 | NP_115997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO18B | ENST00000335473.12 | c.4225-33G>C | intron_variant | 1 | NM_032608.7 | ENSP00000334563.8 | ||||
MYO18B | ENST00000407587.6 | c.4228-33G>C | intron_variant | 1 | ENSP00000386096.2 | |||||
MYO18B | ENST00000536101.5 | c.4225-33G>C | intron_variant | 1 | ENSP00000441229.1 | |||||
MYO18B | ENST00000539302.5 | n.*1683-33G>C | intron_variant | 1 | ENSP00000437587.1 |
Frequencies
GnomAD3 genomes AF: 0.435 AC: 66136AN: 151946Hom.: 14889 Cov.: 32
GnomAD3 genomes
AF:
AC:
66136
AN:
151946
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.478 AC: 77637AN: 162462Hom.: 19408 AF XY: 0.468 AC XY: 40059AN XY: 85506
GnomAD3 exomes
AF:
AC:
77637
AN:
162462
Hom.:
AF XY:
AC XY:
40059
AN XY:
85506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.462 AC: 639519AN: 1385120Hom.: 149795 Cov.: 23 AF XY: 0.461 AC XY: 315710AN XY: 684596
GnomAD4 exome
AF:
AC:
639519
AN:
1385120
Hom.:
Cov.:
23
AF XY:
AC XY:
315710
AN XY:
684596
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.435 AC: 66163AN: 152064Hom.: 14898 Cov.: 32 AF XY: 0.438 AC XY: 32567AN XY: 74316
GnomAD4 genome
AF:
AC:
66163
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
32567
AN XY:
74316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1536
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at